Co-Authors
This is a "connection" page, showing publications co-authored by Gerard Curley and Oliver McElvaney.
Connection Strength
2.593
-
Reply to Blot et al. and to Inoue et al. Am J Respir Crit Care Med. 2021 01 01; 203(1):141-142.
Score: 0.922
-
a1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome? Anesthesiology. 2021 05 01; 134(5):792-808.
Score: 0.236
-
Interleukin-6: obstacles to targeting a complex cytokine in critical illness. Lancet Respir Med. 2021 06; 9(6):643-654.
Score: 0.235
-
Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients. BMC Res Notes. 2021 Jan 09; 14(1):20.
Score: 0.231
-
Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19. J Cyst Fibros. 2021 01; 20(1):31-35.
Score: 0.229
-
Corrigendum to 'A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19'. EBioMedicine. 2020 Dec; 62:103116.
Score: 0.228
-
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine. 2020 Nov; 61:103026.
Score: 0.227
-
Characterization of the Inflammatory Response to Severe COVID-19 Illness. Am J Respir Crit Care Med. 2020 09 15; 202(6):812-821.
Score: 0.226
-
Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One. 2021; 16(8):e0256226.
Score: 0.060